Paul Allen
Vice President, Strategic Services
As vice president of strategic services at Olson Research Group, Paul is responsible for developing new services designed specifically for the pharmaceutical, biotechnology, and medical devices industries. He is also charged with leading an external team of experienced partners and consultants who specialize in delivering solutions to these industries.
With nearly three decades of professional experience in the industry, Paul brings a love of science and a wealth of business perspective, expertise and leadership to Olson’s practice. One of his greatest professional accomplishments is his ability to transition from science to business and then to integrate those areas into a professional development plan that has consistently grown with increasing responsibility.
Prior to Olson, Paul was the President of Genactis, Inc., a firm that specialized in research based consulting and focused on early stage product development engagements across the life sciences business sector. Paul spent 9 years at Clarkston Consulting where he was the managing partner for their global life sciences practice. He spent 4 years at IMS Health, where he served as vice president of marketing, and was responsible for more than 60 marketing and sales professionals. Prior to IMS Health, Paul was responsible for managing the sales and operations, market research, and business development for Novo Nordisk Pharmaceuticals.
Mr. Allen has moderated numerous industry conferences focused on issues within the pharmaceutical industry, from preparing for FDA inspections to developing a “risk management approach” to quality systems strategies. He has been a member of several industry advisory boards and as such has had an impact on guiding the way organizations navigate the issues driving business strategy. He has been called on to act as an expert witness in a number of drug patent cases based on his broad knowledge and expertise in the industry. In addition, Mr. Allen has experience in regulatory compliance (both for commercial operations and manufacturing areas), business process redesign, government pricing and contracting strategies and systems, and business intelligence systems.
He has been a featured speaker at national and international pharmaceutical conferences where he covered topics from FDA regulatory compliance, to e- marketing and direct-to-consumer strategies, to supply chain optimization in Life Sciences and sales force productivity through innovative compensation methods.
View My LinkedIn Profile »